Polymorphisms in the gene encoding CYP1A2 influence prostate cancer risk and progression.
CYP1A2
Slovak population
haplotype
polymorphism
prostate cancer
Journal
Oncology letters
ISSN: 1792-1082
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
13
10
2022
accepted:
16
12
2022
entrez:
10
2
2023
pubmed:
11
2
2023
medline:
11
2
2023
Statut:
epublish
Résumé
The role of the cytochrome P450 1A2 (
Identifiants
pubmed: 36760517
doi: 10.3892/ol.2023.13671
pii: OL-25-2-13671
pmc: PMC9878356
doi:
Types de publication
Journal Article
Langues
eng
Pagination
85Informations de copyright
Copyright: © Vilčková et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Nat Rev Cancer. 2006 Dec;6(12):947-60
pubmed: 17128211
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W71-4
pubmed: 17485472
Oncotarget. 2017 Jun 13;8(24):38367-38377
pubmed: 28418906
Carcinogenesis. 2000 Sep;21(9):1683-9
pubmed: 10964100
Neoplasma. 2015;62(5):683-91
pubmed: 26278153
Cancer Res. 2009 Mar 15;69(6):2340-8
pubmed: 19276377
Pharmaceutics. 2021 Sep 22;13(10):
pubmed: 34683828
AAPS J. 2009 Sep;11(3):481-94
pubmed: 19590965
Clin Pharmacol Ther. 2002 Mar;71(3):141-52
pubmed: 11907488
Environ Health Prev Med. 2017 Oct 24;22(1):72
pubmed: 29165164
Biochem Pharmacol. 2001 Apr 1;61(7):843-9
pubmed: 11274970
Hum Exp Toxicol. 2000 Oct;19(10):573-95
pubmed: 11211997
Clin Transl Oncol. 2020 Oct;22(10):1667-1680
pubmed: 32170639
Carcinogenesis. 2011 Feb;32(2):203-9
pubmed: 21081473
Eur J Cancer Prev. 2013 Nov;22(6):607-19
pubmed: 23462460
Br J Clin Pharmacol. 1996 Jul;42(1):91-8
pubmed: 8807149
Altern Med Rev. 1998 Jun;3(3):187-98
pubmed: 9630736
Cancer Lett. 2005 Sep 28;227(2):115-24
pubmed: 16112414
Pharmacogenetics. 2002 Aug;12(6):473-8
pubmed: 12172216
Pharmacogenomics. 2008 May;9(5):625-37
pubmed: 18466106
Cancer Lett. 2015 Jan 28;356(2 Pt A):231-43
pubmed: 24784887
Biochem J. 1990 Jul 15;269(2):437-41
pubmed: 2117439
Am J Surg Pathol. 2020 Aug;44(8):e87-e99
pubmed: 32459716
Zhonghua Nan Ke Xue. 2011 Nov;17(11):998-1001
pubmed: 22141270
Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
Brief Bioinform. 2002 Jun;3(2):146-53
pubmed: 12139434
Meta Gene. 2015 May 22;5:1-8
pubmed: 26042205
Cancer Lett. 2001 Apr 26;165(2):171-7
pubmed: 11275366
Clin Liver Dis. 2017 Feb;21(1):1-20
pubmed: 27842765
Pharmacogenetics. 1995 Oct;5(5):259-74
pubmed: 8563766
Pharmacogenet Genomics. 2006 Mar;16(3):219-27
pubmed: 16495781
Urology. 2009 May;73(5 Suppl):S11-20
pubmed: 19375622
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):969-78
pubmed: 17507624
Adv Exp Med Biol. 2016;911:23-32
pubmed: 26987327
Eur J Clin Pharmacol. 2008 Apr;64(4):381-5
pubmed: 18157525
Am J Surg Pathol. 2016 Feb;40(2):244-52
pubmed: 26492179
Bioinformatics. 2005 Jan 15;21(2):263-5
pubmed: 15297300
Cancer Med. 2014 Dec;3(6):1644-55
pubmed: 25355624
Basic Clin Pharmacol Toxicol. 2005 Sep;97(3):125-34
pubmed: 16128905
Am J Epidemiol. 2012 Feb 15;175(4):289-301
pubmed: 22247046
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
PLoS One. 2009 May 21;4(5):e5652
pubmed: 19479063
J Toxicol Environ Health B Crit Rev. 2008 Mar;11(3-4):242-59
pubmed: 18368555
Cancer Res. 1997 Nov 1;57(21):4757-64
pubmed: 9354437
Cancer Genomics Proteomics. 2022 May-Jun;19(3):362-371
pubmed: 35430569
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Eur J Clin Pharmacol. 2007 Jun;63(6):537-46
pubmed: 17370067
Carcinogenesis. 2012 Nov;33(11):2108-18
pubmed: 22822096
Adv Pharmacol. 2015;74:85-111
pubmed: 26233904
Nat Protoc. 2011 Feb;6(2):121-33
pubmed: 21293453
Cell Mol Life Sci. 2001 May;58(5-6):737-47
pubmed: 11437235
J Steroid Biochem Mol Biol. 2015 Mar;147:24-30
pubmed: 25448748
Anticancer Res. 2020 Nov;40(11):6257-6264
pubmed: 33109563
BMC Cancer. 2016 Feb 10;16:83
pubmed: 26865042
Drug Metab Rev. 2010 May;42(2):268-354
pubmed: 19961320